Li et al., 2010 - Google Patents
A Panel of Rabbit Monoclonal Antibody Marker for Prostate CancerLi et al., 2010
- Document ID
- 13814270804018287112
- Author
- Li A
- Munagala A
- Fernandez E
- Sequar G
- Chen T
- Publication year
- Publication venue
- Journal of Histotechnology
External Links
Snippet
Tumor markers are useful in identification of tumor origin and in analysis of the biological characteristics of specific tumor. The objective of this study was to determine the immunohistochemical application of a panel of rabbit monoclonal antibodies against human …
- 241000283973 Oryctolagus cuniculus 0 title abstract description 15
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10822660B2 (en) | Method for discrimination of metaplasias from neoplastic or preneoplastic lesions | |
| US9429577B2 (en) | Anti-uroplakin II antibodies systems and methods | |
| WO1994007138A1 (en) | Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations | |
| Ghods et al. | High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma | |
| JP2012103264A (en) | Antibody for cancer diagnosis | |
| US9625461B2 (en) | Method of detecting cancer using delta-catenin | |
| Lin et al. | Differential expression of human Dlg in cervical intraepithelial neoplasias | |
| CA2623653C (en) | Use of n-myristoyltransferase on non-tumor tissue for cancer diagnosis | |
| US20130137106A1 (en) | Tumor Marker and Methods of Use Thereof | |
| US10267801B2 (en) | Assay | |
| Li et al. | A Panel of Rabbit Monoclonal Antibody Marker for Prostate Cancer | |
| WO2012010105A1 (en) | Methods for detection of lethal system | |
| Karabatsou et al. | Expression of survivin, platelet-derived growth factor A (PDGF-A) and PDGF receptor α in primary central nervous system lymphoma | |
| US7588898B2 (en) | Biomarker for gestational trophoblastic disease | |
| EP2788766B1 (en) | Lasp-1, a novel urinary marker for transitional cell carcinoma detection | |
| Jensen et al. | Characterization of a novel anti-fatty acid synthase (FASN) antiserum in breast tissue | |
| JP2003043046A (en) | Marker for determining breast cancer and method for determining breast cancer using the marker | |
| JP2013096783A (en) | Data detection method, diagnostic drug and diagnostic kit for determining pulmonary adenocarcinoma | |
| CN116635718A (en) | Anti-human CD10 antibody for use in immunohistochemistry (IHC) protocols to diagnose cancer | |
| EP3124974A1 (en) | Method for the normalization of immunological tests and kits for performing such tests | |
| Munkarah et al. | Role of Immunohistochemical Expression of Cyclooxygenase-2 in Ovarian Serous Carcinoma | |
| NZ623642B2 (en) | Lasp-1, a novel urinary marker for transitional cell carcinoma detection | |
| JPWO2006059712A1 (en) | Monoclonal antibodies that bind to human steroid sulfatase |